Find Funding Opportunities

Extending a receipt date

The Transformative Research to Address Health Disparities and Advance Health Equity initiative is soliciting applications to support unusually innovative intervention research addressing social determinants of health (SDOH), which, if successful, would have a major impact on preventing, reducing, or eliminating health disparities and advancing health equity. Projects must clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact on advancing NIHs commitment to addressing SDOH to accelerate progress in improving health for all. Preliminary data are not required for this initiative.

TBD

This Notice highlights the NINDSs interest in receiving grant applications focused on advancing the careers of a diverse translational research workforce in response to PAR-20-240, NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25).

This Notice announces the reissue of a joint initiative, Collaborative Research in Computational Neuroscience (CRCNS), among six National Science Foundation (NSF) Directorates and Offices (DOs), and nine participating National Institutes of Health (NIH).

Allowing post-submission materials.

The purpose of this notice is to inform the community that the NIH Blueprint and BRAIN Initiative are changing the funding allowance for K00 awards to RFA-NS-21-012, RFA-NS-19-011, and RFA-NS-18-007.This change will apply to all new and continuing NIH Blueprint and BRAIN Initiative F99/K00 awards. Currently, the NIH Blueprint and BRAIN Initiative provides up to $58,000 salary during the K00 phase. Effective for new and continuing K00 awards made with FY2024 funds, the NIH Blueprint and BRAIN Initiative will contribute up to $60,000 in the first year toward the salary of the career award recipient. This will be increased to $63,300 for the second year, to $66,600 for the third year, and to $69,900 for a fourth year.

Changing the receipt dates

Adding a receipt date.

The purpose of this notice is to inform applicants of an extension to PAR-22-030 "Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)". The NOFO will be extended by one additional council round.